Reversal of Neuromuscular Blockade
Conditions
Brief summary
This study evaluate clinical efficacy and safety in adult patients administered BriTurn injection or BrisTurn Prefilled injection for reversal of neuromuscular blockade induced by Rocuronium or Vecuronium.
Detailed description
This study evaluate clinical efficacy and safety in adult patients administered BriTurn injection or BrisTurn Prefilled injection for reversal of neuromuscular blockade induced by Rocuronium or Vecuronium. * Efficacy: Time (minutes) for Train-Of-Four (TOF) ratio to reach 0.9 (90%) * Safety: whether bradycardia and resulting cardiac arrest occur or whether bronchospasm occurs
Interventions
None listed
Sponsors
Hanlim Pharm. Co., Ltd.
Study design
Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adults over 19 years of age * Subject administered BriTurn Injection or BrisTurn Prefilled Injection for reversal of neuromuscular blockade induced by Rocuronium or Vecuronium
Exclusion criteria
* Pregnant women or nursing women * Subject to prohibition according to the permission of BriTurn Injection or BrisTurn Prefilled Injection
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Time (minutes) for Train-Of-Four (TOF) ratio to reach 0.9 (90%) | after administration of BriTurn Injection or BrisTurn Prefilled Injection up to 3 minutes | Time (minutes) for Train-Of-Four (TOF) ratio to reach 0.9 (90%) after administration of BriTurn Injection or BrisTurn Prefilled Injection up to 3 minutes |
Countries
South Korea
Contacts
Primary ContactSangseok Lee
Outcome results
None listed